<DOC>
	<DOCNO>NCT01387412</DOCNO>
	<brief_summary>The primary objective study determine role genital wart ( GW ) Human Immunodeficiency Virus ( HIV ) acquisition among men sex men ( MSM ) Peru . The secondary objective determine Human Papillomavirus ( HPV ) prevalence HIV positive MSM Peru , risk factor associate GW , knowledge HPV HIV among MSM .</brief_summary>
	<brief_title>The Role Genital Warts HIV Acquisition Peru</brief_title>
	<detailed_description>Persons Human Immunodeficiency Virus ( HIV ) infection high risk become infect Human Papillomavirus ( HPV ) compare HIV negative . The contrary also true : individual infect HPV may likely acquire HIV ; however , role clinical manifestation HPV - genital wart ( GW ) - HIV acquisition currently unknown . Few study show GW independently associate HIV acquisition . The primary objective study determine role GW HIV acquisition among MSM Peru . The secondary objective determine HPV prevalence HIV positive MSM Peru , risk factor associate GW , knowledge HPV HIV among MSM . The specific aim study : 1 . To estimate HIV incidence Peruvian MSM GW status . 2 . To determine prevalence HIV among Peruvian MSM GW status . 3 . To determine type-specific prevalence anal HPV infection HIV positive Peruvian MSM . Linear array test estimate prevalence 37 HPV type include carcinogenic ( 16,18 , 31 , 33 , 35 , 39 , 45 , 51 , 52 , 56 , 58 , 59 , 66 ) non-carcinogenic type ( 6 , 11 , 26 , 40 , 42 , 53 , 54 , 61 , 62 , 64 , 67 , 68 , 69 , 70 , 72 , 73 , 81 , 82 , 82var , 83 , 84 , 89 ) define 2005 meeting International Agency Research Cancer . 4 . To identify risk factor associate genital wart ( penile , anal , ) among Peruvian MSM . 5 . To assess knowledge Peruvian MSM role HPV HIV infection . The study conduct Gay Men 's Community Health Center , Epicentro , center Lima specifically cater men sex men see high burden genital wart patient population . The study include population 600 MSM ( 300 recent current genital wart ) . Baseline HIV serostatus do rapid testing , follow-up HIV incidence do every 6 month two year time period . We determine HPV status HIV-positive participant refer free highly active antiretroviral therapy ( HAART ) treatment . We examine participant GW presence collect information history GW . A survey administer visit examines change risk behavior time . This novel study propose measure prevalence GW MSM present community clinic environment prospectively measure HIV incidence men GW without GW . It first study kind aware use HIV infection endpoint men without GW help well understand relationship genital wart HIV infection among MSM Peru .</detailed_description>
	<mesh_term>Warts</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<criteria>Anatomical male 1840 year age , Selfreported anal sex another man within 12 month prior enrollment , Willing provide inform consent collection demographic sexual behavior data , well blood HIV Syphilis testing , swabs anal mucosa HPV test urine Chlamydia testing , Resident metropolitan Lima . Prior participation HPV vaccine clinical trial , Prior participation HIV vaccine clinical trial , Presence know immunodeficiency increase risk acquire HIV .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>genital wart</keyword>
	<keyword>HIV</keyword>
	<keyword>MSM</keyword>
	<keyword>Peru</keyword>
	<keyword>HPV</keyword>
</DOC>